Female Fertility Drugs Market: By Drug Type, (Gonadotrophins, Aromatase Inhibitors, Selective Estrogen Receptor Modulators, Follicle Stimulating Hormones, Dopamine Agonists, Metformin Hydrochloride, Others), By Distribution Mode (Prescription Fertility Drugs, Over-The-Counter Fertility drugs), By Route of Administration (Oral,Parenteral), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Female Fertility Drugs Market size valued at USD 3.48 billion in 2022 is expected to reach USD 5.35 billion in 2028, at a CAGR of 6.3% from 2023-2029. Female fertility drugs are the agents used to improve reproductive health in women and act to stimulate the follicle development of the ovary. Women's fertility drugs are extremely effective and the first treatment option to overcome infertility. Fertility drugs act by direct stimulation of ovaries or balancing the hormone levels. Infertility in women occurs due to hypothalamic dysfunction, excessive prolactin, pelvic inflammatory diseases, premature ovarian insufficiency, and polycystic ovary syndrome among others. The major symptom associated with infertility is an absence or irregular menstrual cycle. The female fertility drugs market is growing at a significant CAGR with several local and international players operating in infertility treatment.

The prevalence of infertility is increasing due to changes in lifestyles such as smoking and alcohol consumption. According to World Health Organization, approximately 60-80 Mn couples are suffering from infertility around the world. Moreover, acquisitions & mergers, collaborations, product approvals, and product launchings are the strategies followed by the companies for increasing their market revenue share in the female fertility drugs market. For instance, in March 2014, Ferring Pharmaceuticals received FDA approval for the combination of Menopur and Bravelle injection used in the treatment of infertility.

Female Fertility Drugs Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.3%

Largest Market

North America

Fastest Growing Market

Europe
Female Fertility Drugs Market Dynamics

Increase in the female population, rise in prevalence of infertility condition due to change in lifestyle, government initiation for the infertility management, rise in disposable income are anticipated to fuel the women fertility drugs market over the forecast period. Moreover, increase in R&D activities for the development of new drugs to overcome the infertility, rise in the prevalence of obesity, and increase in the maternal age are expected to boost the women fertility drugs market. However, stringent regulatory policies for drug approvals, lack of awareness about women fertility drugs in underdeveloped countries, and alternative infertility treatments such as in vitro fertilization are expected to restrain the growth of women fertility drugs market over the forecast period.

Female Fertility Drugs Market Segmentation

By Drug Type
  • Gonadotrophins
  • Aromatase Inhibitors
  • Selective Estrogen Receptor Modulators
  • Follicle Stimulating Hormones
  • Dopamine Agonists
  • Metformin Hydrochloride
  • Others
By Route Administration
  • Oral
  • Parenteral
By Distribution Channel
  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies
By Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East Africa

Frequently Asked Questions

The Female fertility drugs market size was valued at USD 3.48 billion in 2022.

The Female fertility drugs market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

The Female fertility drugs market key players are Sanofi S.A. (France), Merck KGaA (Germany), Novartis AG (Switzerland), Ferring B.V. (Switzerland), Berlex Laboratories Inc. (U.S.), Eli Lilly and Co. (U.S.), Serono Inc. (U.S.), Novogyne Pharmaceuticals (U.S.), Pfizer, Inc. (U.S.)

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  1. Executive Summary
  2. Global Female Fertility Drugs Market Introduction
    • Global Female Fertility Drugs Market Taxonomy
    • Global Female Fertility Drugs Market Definitions
      • Drug Type
      • Distribution Mode
      • Route of Administration
      • Distribution Channel
  1. Global Female Fertility Drugs Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Female Fertility Drugs Market Dynamic Factors - Impact Analysis
    • Global Female Fertility Drugs Market Competition Landscape
    • Epidemiology
  2. Global Female Fertility Drugs Market Analysis,2018-2022 and Forecast, 2023-2029
    • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Female Fertility Drugs Market, By Drug Type, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
    • Gonadotrophins
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Aromatase Inhibitors
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Selective Estrogen Receptor Modulators
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Follicle Stimulating Hormones
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Dopamine Agonists
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Metformin Hydrochloride
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Female Fertility Drugs Market Forecast, By Distribution Mode,2018-2022 and Forecast, 2018 2024
    • Prescription Fertility Drugs
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Over-The-Counter Fertility drugs
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Female Fertility Drugs Market Forecast, By Route of Administration,2018-2022 and Forecast, 2023-2029
    • Oral
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Parenteral
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Female Fertility Drugs Market Forecast, By Distribution Channel, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
    • Hospital Pharmacies
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail Pharmacies
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacies
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Female Fertility Drugs Market Forecast, By Region, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Female Fertility Drugs Market - Opportunity Analysis Index, By Drug Type, By Distribution Mode, By Route of Administration, By Distribution Channel and Region, 2023-2029
  2. North America Female Fertility Drugs MarketAnalysis,2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
    • Drug Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Gonadotrophins
      • Aromatase Inhibitors
      • Selective Estrogen Receptor Modulators
      • Follicle Stimulating Hormones
      • Dopamine Agonists
      • Metformin Hydrochloride
      • Others
    • Distribution Mode Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription Fertility Drugs
      • Over-The-Counter Fertility drugs
    • Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital pharmacies
      • Retail pharmacies
      • Online pharmacies
    • Country Analysis 2016 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US
      • Canada
    • North America Female Fertility Drugs Market - Opportunity Analysis Index, By Drug Type, By Distribution Mode, By Route of Administration, By Distribution Channel and Country, 2023-2029
    • North America Female Fertility Drugs Market Dynamics Trends
  3. Europe Female Fertility Drugs Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
    • Drug Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Gonadotrophins
      • Aromatase Inhibitors
      • Selective Estrogen Receptor Modulators
      • Follicle Stimulating Hormones
      • Dopamine Agonists
      • Metformin Hydrochloride
      • Others
    • Distribution Mode Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription Fertility Drugs
      • Over-The-Counter Fertility drugs
    • Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital pharmacies
      • Retail pharmacies
      • Online pharmacies
    • Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Female Fertility Drugs Market - Opportunity Analysis Index, By Drug Type, By Distribution Mode, By Route of Administration, By Distribution Channel and Country, 2023-2029
    • Europe Female Fertility Drugs Market Dynamics Trends
  4. Asia-Pacific Female Fertility Drugs Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
    • Drug Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Gonadotrophins
      • Aromatase Inhibitors
      • Selective Estrogen Receptor Modulators
      • Follicle Stimulating Hormones
      • Dopamine Agonists
      • Metformin Hydrochloride
      • Others
    • Distribution Mode Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription Fertility Drugs
      • Over-The-Counter Fertility drugs
    • Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital pharmacies
      • Retail pharmacies
      • Online pharmacies
    • Country Analysis2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Female Fertility Drugs Market - Opportunity Analysis Index, By Drug Type, By Distribution Mode, By Route of Administration, By Distribution Channel and Country, 2018 2024
    • Asia-Pacific Female Fertility Drugs Market Dynamics Trends
  5. Latin America Female Fertility Drugs Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
    • Drug Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Gonadotrophins
      • Aromatase Inhibitors
      • Selective Estrogen Receptor Modulators
      • Follicle Stimulating Hormones
      • Dopamine Agonists
      • Metformin Hydrochloride
      • Others
    • Distribution Mode Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription Fertility Drugs
      • Over-The-Counter Fertility drugs
    • Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital pharmacies
      • Retail pharmacies
      • Online pharmacies
    • Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Female Fertility Drugs Market - Opportunity Analysis Index, By Drug Type, By Distribution Mode, By Route of Administration, By Distribution Channel and Country, 2023-2029
    • Latin America Female Fertility Drugs Market Dynamics Trends
  6. Middle East and Africa Female Fertility Drugs Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
    • Drug Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Gonadotrophins
      • Aromatase Inhibitors
      • Selective Estrogen Receptor Modulators
      • Follicle Stimulating Hormones
      • Dopamine Agonists
      • Metformin Hydrochloride
      • Others
    • Distribution Mode Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription Fertility Drugs
      • Over-The-Counter Fertility drugs
    • Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital pharmacies
      • Retail pharmacies
      • Online pharmacies
    • Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Female Fertility Drugs Market - Opportunity Analysis Index, By Drug Type, By Distribution Mode, By Route of Administration, By Distribution Channel and Country, 2023-2029
    • MEA Female Fertility Drugs Market Dynamics Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Drug Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Sanofi S.A. (France)
      • Merck KGaA (Germany)
      • Novartis AG (Switzerland)
      • Ferring B.V. (Switzerland)
      • Berlex Laboratories Inc. (U.S.)
      • Eli Lilly and Co. (U.S.)
      • Serono, Inc. (U.S.)
      • Novogyne Pharmaceuticals (U.S.)
      • Pfizer, Inc. (U.S.)
  1. Research Methodology
  2. Key Assumptions and Acronyms
  • Sanofi S.A. (France)
  • Merck KGaA (Germany)
  • Novartis AG (Switzerland)
  • Ferring B.V. (Switzerland)
  • Berlex Laboratories Inc. (U.S.)
  • Eli Lilly and Co. (U.S.)
  • Serono, Inc. (U.S.)
  • Novogyne Pharmaceuticals (U.S.)
  • Pfizer, Inc. (U.S.)

Adjacent Markets